Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures


Kurt M., Onal I. K. , Akdogan M., Kekilli M., Arhan M., Sayilir A., ...Daha Fazla

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, cilt.24, ss.380-384, 2010 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 24 Konu: 6
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1155/2010/896819
  • Dergi Adı: CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
  • Sayfa Sayıları: ss.380-384

Özet

OBJECTIVE: To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures.